Starting at the lowest effective dose (30 mg) and titrating slowly (increasing by 10 to 20 mg per week) allows the prescriber to catch anxiety escalation before it becomes intolerable
These include mono agonists, glucagonlike peptide-1 receptor agonists (GLP-1 agonists), and dual agonists that combine a glucose-dependent insulinotropic polypeptide (GIP) with a GLP-1 agonist (GIP/GLP-1), which have demonstrated a 15% and greater weight loss in people with obesity and/or type 2 diabetes, says Richard E
Lacy BE, et al
J., Zhuang, X., Tammela, T., Schietinger, A
Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study
Daily dosing has both advantages and disadvantages